VP
Venkata Pratap Reddy Gajulapalli
About Venkata Pratap Reddy Gajulapalli
Data last updated:
Venkata Pratap Reddy Gajulapalli is a Director at Synthenta Private Limited (since 2023) and Designated Partner at Psd Pharmaceuticals Llp (since 2026). The companies operate in Wood. The largest current company by reported revenue is Synthenta Private Limited at ₹82.3 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Jul 2023 | 2023 | ₹82.3 Lakh (FY 2024) | Active | |
| Designated Partner | 31 Jul 2026 | 2026 | Active |
Board colleagues of Venkata Pratap Reddy Gajulapalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sruthi Reddy Gajulapalli | 10222530 | Synthenta Private Limited , Psd Pharmaceuticals Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkata Pratap Reddy Gajulapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkata Pratap Reddy Gajulapalli
Venkata Pratap Reddy Gajulapalli currently holds 2 directorships: Synthenta Private Limited (Director, since 03 Jul 2023, revenue ₹82.3 Lakh (FY 2024)); Psd Pharmaceuticals Llp (Designated Partner, since 31 Jul 2026).
Venkata Pratap Reddy Gajulapalli was first appointed on 03 Jul 2023 as Director at Synthenta Private Limited. The most recent appointment on record is 31 Jul 2026 at Psd Pharmaceuticals Llp.
The current boards of Venkata Pratap Reddy Gajulapalli's companies include Sruthi Reddy Gajulapalli (Synthenta Private Limited).